212 related articles for article (PubMed ID: 19904827)
1. Liposomes with high encapsulation capacity for paclitaxel: Preparation, characterisation and in vivo anticancer effect.
Koudelka S; Turánek-Knötigová P; Masek J; Korvasová Z; Skrabalová M; Plocková J; Bartheldyová E; Turánek J
J Pharm Sci; 2010 May; 99(5):2309-19. PubMed ID: 19904827
[TBL] [Abstract][Full Text] [Related]
2. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol).
Fu H; Shi K; Hu G; Yang Y; Kuang Q; Lu L; Zhang L; Chen W; Dong M; Chen Y; He Q
J Pharm Sci; 2015 Mar; 104(3):1160-73. PubMed ID: 25449709
[TBL] [Abstract][Full Text] [Related]
4. Liposomal paclitaxel formulations.
Koudelka S; Turánek J
J Control Release; 2012 Nov; 163(3):322-34. PubMed ID: 22989535
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route.
Muley P; Kumar S; El Kourati F; Kesharwani SS; Tummala H
Int J Pharm; 2016 Mar; 500(1-2):32-41. PubMed ID: 26792170
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes.
Jiménez-López J; Bravo-Caparrós I; Cabeza L; Nieto FR; Ortiz R; Perazzoli G; Fernández-Segura E; Cañizares FJ; Baeyens JM; Melguizo C; Prados J
Biomed Pharmacother; 2021 Jan; 133():111059. PubMed ID: 33378963
[TBL] [Abstract][Full Text] [Related]
7. Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: improved pharmacokinetics and biodistribution in tumor-bearing mice.
Wang X; Deng L; Chen X; Pei H; Cai L; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Mar; 100(3):1196-205. PubMed ID: 20860011
[TBL] [Abstract][Full Text] [Related]
8. Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol.
Huang ST; Wang YP; Chen YH; Lin CT; Li WS; Wu HC
Int J Oncol; 2018 Sep; 53(3):1105-1117. PubMed ID: 29956746
[TBL] [Abstract][Full Text] [Related]
9. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
[TBL] [Abstract][Full Text] [Related]
10. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
Jain S; Kumar D; Swarnakar NK; Thanki K
Biomaterials; 2012 Oct; 33(28):6758-68. PubMed ID: 22748771
[TBL] [Abstract][Full Text] [Related]
11. A targeting drug delivery system for ovarian carcinoma: transferrin modified lipid coated paclitaxel-loaded nanoparticles.
Li R; Zhang Q; Wang XY; Chen XG; He YX; Yang WY; Yang X
Drug Res (Stuttg); 2014 Oct; 64(10):541-7. PubMed ID: 24443309
[TBL] [Abstract][Full Text] [Related]
12. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
[TBL] [Abstract][Full Text] [Related]
13. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
15. Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy.
Sharma D; Chelvi TP; Kaur J; Chakravorty K; De TK; Maitra A; Ralhan R
Oncol Res; 1996; 8(7-8):281-6. PubMed ID: 8938791
[TBL] [Abstract][Full Text] [Related]
16. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles.
Bao QY; Zhang N; Geng DD; Xue JW; Merritt M; Zhang C; Ding Y
Int J Pharm; 2014 Dec; 477(1-2):408-15. PubMed ID: 25455782
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
18. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
[TBL] [Abstract][Full Text] [Related]
19. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
Ravar F; Saadat E; Gholami M; Dehghankelishadi P; Mahdavi M; Azami S; Dorkoosh FA
J Control Release; 2016 May; 229():10-22. PubMed ID: 26968799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]